Phase II study of tolerance and efficacy of hyperfractionated radiotherapy and 5-fluorouracil, cisplatin, and paclitaxel (Taxol) in stage III and IV inoperable and/or unresectable head-and-neck squamous cell carcinoma: A-2 protocol.
about
Feasibility, toxicity, and efficacy of short induction chemotherapy of docetaxel plus cisplatin or carboplatin (TP) followed by concurrent chemoradio-therapy for organ preservation in advanced cancer of the hypopharynx, larynx, and base of tongue. EDefinitive radiochemotherapy of advanced head and neck cancer with carboplatin and paclitaxel : a phase II study.Esophageal cancer: current and emerging therapy modalities.Long-term outcomes and toxicity of concurrent paclitaxel and radiotherapy for locally advanced head-and-neck cancer.Osteoradionecrosis in cancer patients: the evidence base for treatment-dependent frequency, current management strategies, and future studies.
P2860
Phase II study of tolerance and efficacy of hyperfractionated radiotherapy and 5-fluorouracil, cisplatin, and paclitaxel (Taxol) in stage III and IV inoperable and/or unresectable head-and-neck squamous cell carcinoma: A-2 protocol.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
2002年论文
@zh
2002年论文
@zh-cn
name
Phase II study of tolerance an ...... cell carcinoma: A-2 protocol.
@en
type
label
Phase II study of tolerance an ...... cell carcinoma: A-2 protocol.
@en
prefLabel
Phase II study of tolerance an ...... cell carcinoma: A-2 protocol.
@en
P2093
P1476
Phase II study of tolerance an ...... cell carcinoma: A-2 protocol.
@en
P2093
Alan Lewin
Andre Abitbol
Arnold Markoe
Kara L Hamilton-Nelson
Maria Amelia Rodrigues
May Abdel-Wahab
Michael Troner
P304
P356
10.1016/S0360-3016(02)02816-X
P407
P577
2002-07-01T00:00:00Z